Skip to main content
. 2022 Oct 26;12:17979. doi: 10.1038/s41598-022-22341-7

Figure 3.

Figure 3

Ulinastatin in combination with somatostatin analogue is associated with decreasing trends in mortality when compared to somatostatin analogue monotherapy. (OR, odds ratio; CI, confidence interval).